ON Semiconductor (onsemi) shares declined roughly 16% over the past 30 days, falling from about $79.42 on August 18 to $66.60 by the September 16 close. The selloff extends a deeper multi-month slide, with the stock down roughly 44% over the past quarter.

Lam Research (LRCX) shares fell roughly 21.7% over the last 30 days, slipping from about $343.84 in mid-August to $269.23. The slide extends a wider pullback: the stock is down approximately 28% over the last three months and about 38% below its late-June 52-week high near $438.50.

Western Digital (WDC) shares declined roughly 22% over the 30 days through mid-September 2026, falling from about $536 to approximately $417. The slide extends a broader correction, with the stock down more than 40% from its mid-June 2026 peak near $800 intraday.

Nebius Group (NBIS) shares fell roughly 22% over the trailing 30 days, from $268.85 on August 17 to $209.37 on September 16, giving back a large share of their post-earnings rally. The pullback reflects profit-taking after a surge of about 27%–34% on strong Q2 results, followed by renewed AI-safety concerns, higher Treasury yields, and a broader rotation out of AI infrastructure names.

10x Genomics (TXG) shares rose roughly 31% over the trailing 30 days, climbing from about $55.63 to a latest close of $72.68, and touched a new 52-week high. The rally built on a much larger multi-month surge, with the stock up more than 100% over the past quarter and over 300% year to date.

X-Energy (XE) shares fell roughly 28.8% over the last 30 days, from about $20.46 to $14.57, as momentum in small modular reactor (SMR) names faded. The decline accelerated after Piper Sandler initiated coverage with an Underweight rating and a $9 price target in mid-September.

DPC Holdings shares fell roughly 20% over the last 30 days, declining from a close of $49.58 to $39.52. The pullback followed a sharp post-IPO rally that peaked at an intraday high of $57.25 in early August 2026.

Tempus AI (TEM) climbed roughly 35.5% over the trailing 30 days, from about $51.64 to $69.97 on a closing basis. The advance was amplified by a technical short squeeze tied to positive third-party precision-medicine news and an expanded AI collaboration with Merck.

Victoria's Secret & Co. (VSXY) traded near $74 in its most recent session, roughly 35% below the $100 level investors are watching and below its 52-week high of $102.46 set in August 2026. The strongest bullish case rests on a genuine operational turnaround: sharply higher second-quarter earnings, expanding margins, and renewed momentum in beauty and the relaunched PINK brand.

NOWL advanced roughly 34% over the last 30 days , reflecting a sharp rally in its single underlying exposure, ServiceNow ( NOW ). The fund seeks 200% of the daily return of ServiceNow common stock, reset each trading day; results over longer periods compound and can diverge from a simple 2x multiple.

DLLL is an actively managed, single-stock leveraged ETF that targets 200% (2x) of the daily return of Dell Technologies ( DELL ), before fees and expenses. Over the trailing 30 days, the fund moved modestly higher (roughly +4%) but with pronounced day-to-day volatility, reflecting Dell's post-earnings surge followed by a sharp pullback.

HOOW gained approximately 19% over the last 30 days, amplifying a sharp rally in Robinhood Markets (HOOD) through 1.2x weekly leverage. The fund is an actively managed, non-diversified ETF that targets 120% of HOOD's calendar-week total return while making weekly distributions to shareholders.

AAPU advanced roughly 17% over the trailing 30 days, more than doubling the single-digit gain in the underlying Apple stock it tracks. The move reflects AAPU's 2X daily leverage target, which amplifies Apple's daily returns in both directions.

The United States Gasoline Fund (UGA) gained roughly 16% over the trailing 30 days, tracking a sharp rally in near-month gasoline futures. The move extends a broader uptrend, with the fund up approximately 31% over the trailing quarter and more than 90% year to date.

IMPP closed up +0.52% at $5.80 in regular trading, a modest gain versus the prior session's $5.77 close. The advance extends post-earnings momentum following record Q2 results reported Sept. 10: revenue of $87.1M (+140% YoY) and EPS of $0.76, beating the $0.73 consensus.

The central question is whether SOPHiA GENETICS SA (SOPH) can climb to a $10 stock price target, roughly 25% above recent trading levels. Bullish drivers include accelerating revenue growth, raised full-year guidance, expanding U.S. traction, and high-profile companion-diagnostics partnerships.

RACC shares fell roughly 58.7% over the past 30 days, sliding from about $26.50 in mid-August to near $10.95 as of mid-September. The drop unwound a sharp summer rally that carried the thinly traded U.S.-listed shares from around $11 in mid-July to an intraday peak above $33 in mid-August.

ALMS fell -6.07% to about $7.89 during regular trading, extending the prior session's slide. The move follows the Phase 2b LUMUS lupus trial readout, which missed its primary and secondary endpoints in the broader SLE population.

Swarmer (SWMR) is up +4.17% intraday during regular market hours, trading near $24.00 versus a $23.04 prior close. The bounce follows a sharp selloff — shares fell -28.36% on Sept. 15 and are down more than -40% this week.

TWM seeks daily investment results corresponding to -2x the Russell 2000 Index, while TZA targets -3x, resulting in higher volatility and potential compounding effects for TZA over multiple days. Both ETFs provide inverse exposure to the same underlying benchmark of approximately 2,000 small-capitalization U.S. companies but differ in leverage levels, affecting risk profiles and suitability for short-term hedging versus tactical trading.